This article summarizes the historical background for the use of oxygen during newborn resuscitation and describes some of the research and the process of changing the previous practice from a high-to a low-oxygen approach. Findings of a recent Cochrane review suggest that more than 100 000 newborn lives might be saved globally each year by changing from 100 to 21% oxygen for newborn resuscitation. This estimate represents one of the largest yields for a simple therapeutic approach to decrease neonatal mortality in the history of pediatric research. Available data also suggest that, for the very low birth weight infant, use of the low-oxygen approach should be considered with the understanding that some of the smallest and sickest preterm neonates will need some level of oxygen supplementation during the first minutes of postnatal life. As more data are needed for the very preterm population, creation of strict guidelines for these infants would be premature at present. However, it can be stated that term and late preterm infants in need of resuscitation should, in general, be started on 21% oxygen, and if resuscitation is not started with 21% oxygen, a blender should be available, enabling the administration of the lowest FiO 2 possible to keep heart rate and SaO 2 within the target range. For extremely low birth weight infants, initial FiO 2 could be between 0.21 and 0.30 and adjusted according to the response in SaO 2 and heart rate.
Background
The history of the use of oxygen in newborn resuscitation has been recently summarized by Obladen. 1 Briefly, oxygen was introduced in newborn care more than 200 years ago. In 1777, Dr Chaussier developed a device for the use of oxygen in neonatal resuscitation and made oxygen the first drug to be used specifically in neonates. Within a few years, oxygen was widely used in neonatal resuscitation throughout Europe and it was even injected intravenously into the umbilical vein of asphyxiated newborn infants. 1 The Apgar score with the inclusion of skin color also contributed to an increased use of oxygen. In 1966, Klaus and Meyer wrote: 'there is no contraindication to the use of warm 100% oxygen during resuscitation. The birth process is an asphyxia episode, and high concentrations of oxygen during the first minutes of life can only be helpful.' 2 It is surprising how earlier generations introduced this therapy and how one generation followed the next without asking critical questions about its validity. It is interesting, perhaps even shocking, to realize that oxygen therapy was introduced without any scientific evidence. It is even more surprising that only few questioned this routine during the ensuing years. The 1992 International Liaison Committee on Resuscitation (ILCOR) guidelines for newborn resuscitation stated that 'oxygen should be used, it is not toxic and there is no reason to be concerned.' 3 However, in 1966 Campbell et al. 4 had already shown in newborn rabbits that it is possible to resuscitate with room air.
I became concerned about the potential harm of using 100% oxygen in resuscitation and raised this issue in 1980.
5 On the basis of our studies showing that the purine metabolite, hypoxanthine, accumulates during hypoxia, we and others understood that introducing oxygen in the aftermath of hypoxia could lead to an explosive generation of oxygen-free radicals. 5, 6 These studies represent the basis for understanding the hypoxia-reoxygenation or ischemia-reperfusion injury that has puzzled medicine far beyond neonatology. This point is clearly illustrated in a recent study in asphyxiated term newborn lambs, in which resuscitation with 21%, 100% for 3 min or 100% for 30 min showed a very high subcortical pO 2 when oxygen supplementation was used ( Figure 1 ). 7 Indeed, if oxygen had been considered as a drug, many of the pitfalls by the liberal use of oxygen could have been avoided.
Discovery through a failure
In 1980, I stated that oxygen supplementation should be reduced during resuscitation in both adults and newborn infants, but I did not investigate this issue further at that time. Instead, I focused on how oxygen radicals could injure premature infants, creating what I called 'The oxygen radical disease of neonatology'. some experiments to study necrotizing enterocolitis in rat intestine, which turned out to be a failure. To help him out, I suggested at that time to test instead the use of room air in resuscitation in a newborn piglet model we had developed. His results showed for the first time that it is possible indeed to resuscitate with 21%. 9 Another PhD fellow, Terje Rootwelt, continued the study by first developing a refined newborn model. In this and a series of subsequent experiments, we confirmed that 21% oxygen is as efficient as 100% oxygen for resuscitation. [10] [11] [12] [13] [14] [15] [16] The findings in the newborn piglet were consistent, and I realized that the time had come to test our hypothesis in a clinical study. Siddarth Ramji in New Delhi immediately agreed to participate, and the pilot clinical trial was carried out in India, enrolling 84 newborn infants randomized to room air or 100% oxygen resuscitation. We found that babies resuscitated in room air recovered as quickly as those who received 100% oxygen. 17 I assumed that this study would trigger hectic research activity by other groups, but not much happened. I realized, therefore, that a larger study was needed to be conducted. The Resair 2 ('resuscitation of newborn infants with room air or oxygen') study was conducted with enrollment of 609 infants from 10 centers in India, Egypt, Spain, Philippines, Estonia and Norway between 1994 and 1996. 18 Findings of the Resair 2 study confirmed the results of the pilot study that newborn infants in need of resuscitation at birth could be resuscitated effectively with room air. 18 In addition, the Resair 2 study showed a trend toward reduced neonatal mortality in neonates resuscitated in room air compared with those resuscitated with 100% oxygen (odds ratio 0.69; 95% confidence interval 0.44 to 1.06). Further, Apgar scores at 5 min were significantly higher in neonates resuscitated in room air compared with those resuscitated with 100% oxygen. Five years later, we published a follow-up study of a subset of the Resair 2 babies, showing that neurodevelopmental outcomes at 18 to 24 months of age were not different in surviving babies between the groups. 19 Subsequent experimental studies and clinical studies by Max Vento and his group and others have been extremely important, as these studies presented evidence that it is actually harmful to resuscitate newborn babies with 100% oxygen. [20] [21] [22] [23] [24] [25] [26] The Resair 2 study was criticized mainly for two reasons. First, the study was not strictly randomized nor was it blinded. Second, most of the babies were enrolled in low income countries and even the ethics of conducting such a study were questioned by some. In contrast, it is interesting that no one had ever objected to the use of pure oxygen for newborn resuscitation, a drug that had never been tested in a randomized controlled study. As late as 2000, as information on the potential benefits of the new low-oxygen approach was spreading, it was still stated by one author: 'Oxygen should be used as soon as possible, in as near 100% as possible in all resuscitation situations, and for the early management of injury and illness. Its use will never disadvantage a patient under these circumstances'. 27 I believe this is a lesson teaching us to be always cautious about our conclusions, especially as now we understand that using 100% oxygen gives reason for concern.
A slow change in attitudes The ILCOR guidelines of 1992 had absolutely no reservation in using pure oxygen for newborn resuscitation. 3 The guidelines of 1999 somewhat modified this view. 28 I had the privilege to take part in the preparation of these guidelines and agreed to myself that there was not sufficient data to change the practice at that time. It was, however, an important signal from ILCOR and from the American Academy of Pediatrics when it was stated that, if oxygen is not available, ambient air should be used. Nevertheless the 1999/2000 guidelines remained quite conservative and cautious, whereas in 1998, the World Health Organization stated that room air should be the first choice for basic newborn resuscitation. 29 The next set of ILCOR/American Academy of Pediatrics guidelines of 2005/6 went a step further and declared that the optimal oxygen concentration for newborn resuscitation is not known. 30 At that time, much data had accumulated regarding the toxic effects of pure oxygen resuscitation, and many of us regarded these guidelines to be conservative. However, these guidelines gave freedom to every country, institution and clinician to choose the initial FiO 2 considered optimal for newborn resuscitation in the given situation. This explains why some institutions started using 21% oxygen and others 100% oxygen for newborn resuscitation, yet everybody was referring to the same guidelines.
Meta-analyses and systematic reviews To date, four meta-analyses and systematic reviews have been published on the use of 21 or 100% oxygen in term and late preterm infants in need of resuscitation. [31] [32] [33] [34] In the view of the available data, all these papers have come to similar conclusions: 21% is as efficient as 100% oxygen in restoring heart rate and spontaneous ventilation in depressed newborn infants. Further, all of the meta-analyses and systematic reviews conclude that neonatal mortality is significantly reduced in those resuscitated with 21% compared with neonates resuscitated with 100% oxygen. The most recently published meta-analysis included 10 studies and 2134 infants enrolled. Neonatal mortality was 12.8% in the group resuscitated in 100% oxygen and 8.2% in the group of patients resuscitated with 21% oxygen, giving a relative risk for neonatal death of 0.69 (95% confidence interval: 0.54 to 0.82) in favor of the 21% group. Six of the studies included in this analysis, enrolling 449 babies, were strictly randomized. All of these studies were from Europe, mainly from Spain. In this subset, relative risk for neonatal death in favor of 21% was as low as 0.32 (95% confidence interval: 0.12 to 0.85). This indicates an almost 70% reduction in neonatal death by switching from 100 to 21% oxygen for newborn resuscitation in developed countries. 31 In the same article, a tendency toward a reduction in hypoxic ischemic encephalopathy was also found, with relative risk of 0.88 for the babies resuscitated in 21% oxygen compared with the neonates resuscitated in 100% oxygen, with a 95% confidence interval of 0.72 to 1.08. This is in agreement with the findings of numerous animal experiments showing that a brief exposure of oxygen following hypoxia has dramatic deleterious effects on the newborn brain. 20, 21, 24, 25 It has been shown that the first breath is delayed by 30 s in babies resuscitated with 100% compared with those resuscitated with 21% oxygen. Heart rate at 90 s and the 5-m Apgar score were also lower when 100% oxygen was applied. 31 The present resuscitation algorithm is based on exactly 30-s steps. This means that an infant who is not responding properly to ventilation after 30 s is moved to chest compressions, and after another 30 s is given epinephrine.
30 The 30-s delay in restoring ventilation in the babies exposed to 100% oxygen therefore, indicates that more of these babies will be receiving chest compressions and medications such as epinephrine.
Two studies in newborn animals 35, 36 and one in adult rats 37 have shown that, even in cardiac arrest, room air is as efficient as 100% O 2 in establishing the return of spontaneous circulation. A recent study in newborn mice with respiratory arrest did, however, show a better effect of administration of 100% O 2 than 21% O 2 . 38 However, this study was not a resuscitation study because no ventilation was provided.
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Why is oxygen still used for resuscitation of term babies? More and more units in many countries have changed their practice from a high-to a low-oxygen resuscitation approach. The first country that changed its guidelines to start resuscitation with 21% oxygen was Canada in 2006 40 43 have changed their national guidelines to start with 21% oxygen when resuscitation of newborns is required. Increasingly, more units in the United States also have switched to the low-oxygen approach. In many European centers, 21% oxygen has been now routine for over 15 years, and very few centers start with administration of 100% oxygen now. Many centers not starting with 21% oxygen start, for instance, with 40% oxygen and turn down the FiO 2, according to the clinical condition or pulse oximetry readings. However, there are no data available on the efficacy and safety of this 'in between' approach.
Preterm infants
The Netherlands was the first country to include preterm infants in their room-air resuscitation guidelines. 42 However, contrary to that in late preterm and term neonates, there is not much evidence to support exact recommendations for the initial FiO 2 when very low birth weight infants need resuscitation at birth. There are presently three smaller randomized studies [44] [45] [46] and an observational study 47 published, and their findings suggest that the smallest infants should also be started with a low-oxygen approach. Findings of a recent study indicate that it is feasible to initiate delivery room stabilization with <100% oxygen in very low birth weight infants when the FiO 2 is being adjusted according to postductal SaO 2 values. 48 In addition, preterm infants <35 weeks of gestation in need of resuscitation had evidence of lower levels of oxidative stress when FiO 2 was titrated according to pulse oximetry than when 100% O 2 was used. 49 From the emerging data it seems that an FiO 2 of 1.0 or 0.9 is too high for preterm infants in need of stabilization/ resuscitation at birth, whereas 0.21, in many cases, is too low. However, an FiO 2 of 0.3 seems to be sufficient in most cases for the initiation of the resuscitation process and might result in fewer complications than starting with an FiO 2 of 0.9. 46 A planned large multicenter study ('Presox' trial) will explore this issue in more detail. 50 Time for change There has been a slow but dramatic switch from a high-to a low-oxygen approach for the resuscitation of term neonates worldwide since the last 15 years or so. Meta-analyses but not a single randomized trial indicate that room air resuscitation can reduce neonatal mortality by 30 to 40%. As more than 4 million newborn infants have birth asphyxia globally each year and approximately 1 million die, room-air resuscitation might save more than 100 000 newborn lives each year. The understanding that newborn infants can be resuscitated with ambient air has opened up new resuscitation projects in underdeveloped countries and has thus paved the way for a new momentum and interest in establishing resuscitation programs in these countries as well.
Finally, in his review, Obladen states: 'When in 1780 Chaussier initiated oxygen treatment for neonatal asphyxia, it just seemed logical to him. When in 2005 the ILCOR guidelines, European guidelines, and Cochrane Database gave three different recommendations for the use of oxygen in neonatal resuscitation, the weakness of modern, purportedly evidence-based medicine was revealed. ' 1 Although clearly more data are needed, sufficient evidence supports the ongoing change in attitude toward the use of less oxygen in the resuscitation of term neonates.
Conclusion
Resuscitation of term neonates should no longer be initiated with 100% oxygen. For babies of X32-week gestational age with healthy lungs, it is safe, in most cases, to start resuscitation with 21% O 2 . If a higher FiO 2 is chosen, oxygen concentration should quickly be turned down according to the response of the patient guided by the SaO 2 and heart rate. For newborns of <32-week gestational age, the optimal FiO 2 to initiate resuscitation is not known; however, resuscitation may be started with an FiO 2 between 0.21.to 0.30 and then titrated according to the patient's response.
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